Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD
Charmion Cruickshank‐Quinn, Sean Jacobson, Grant Hughes, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation
Mohammad Arifuzzaman, Tae Hyung Won, Tingting Li, et al.
Nature (2022) Vol. 611, Iss. 7936, pp. 578-584
Closed Access | Times Cited: 120
Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis
Yoon Ok Jang, Se Hee Lee, Jong Jin Choi, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 7, pp. 1128-1139
Open Access | Times Cited: 88
The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD
Qing Song, Ping Chen, Xiangming Liu
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
Enrica Torretta, Micaela Garziano, Mariacristina Poliseno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10198-10198
Open Access | Times Cited: 57
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease
Siddharth Madapoosi, Charmion Cruickshank‐Quinn, Kristopher Opron, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 4, pp. 427-439
Closed Access | Times Cited: 57
Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives
Chin-Ling Li, Shih-Feng Liu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7347-7347
Open Access | Times Cited: 11
Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO)
Nilanjana Ghosh, Priyanka Choudhury, Sandeep Rai Kaushik, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Predictive Modeling for Metabolomics Data
Tusharkanti Ghosh, Weiming Zhang, Debashis Ghosh, et al.
Methods in molecular biology (2020), pp. 313-336
Open Access | Times Cited: 51
Protein Biomarkers for COPD Outcomes
Karina A. Serban, Katherine Pratte, Russell P. Bowler
CHEST Journal (2021) Vol. 159, Iss. 6, pp. 2244-2253
Open Access | Times Cited: 50
Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty
Abilash Ravi, Annika W.M. Goorsenberg, Annemiek Dijkhuis, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 5, pp. 1236-1248
Open Access | Times Cited: 41
Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD
Sharon Mumby, Ian M. Adcock
Journal of Inflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 32
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD
Serena Correnti, Mariaimmacolata Preianò, Fabia Gamboni, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Air pollution, metabolites and respiratory health across the life-course
Olena Gruzieva, Ayoung Jeong, Shizhen He, et al.
European Respiratory Review (2022) Vol. 31, Iss. 165, pp. 220038-220038
Open Access | Times Cited: 27
An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease
Nan Ran, Zhiqiang Pang, Yinuo Gu, et al.
Metabolites (2019) Vol. 9, Iss. 6, pp. 111-111
Open Access | Times Cited: 41
Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General Population
Bing Yu, Claudia Flexeder, Robert W. McGarrah, et al.
Metabolites (2019) Vol. 9, Iss. 4, pp. 61-61
Open Access | Times Cited: 39
Cigarette Smoke Reduces Fatty Acid Catabolism, Leading to Apoptosis in Lung Endothelial Cells: Implication for Pathogenesis of COPD
Jiannan Gong, Hui Zhao, Tanzhen Liu, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 36
Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicine
Tao Zhu, Shanqun Li, Jiajia Wang, et al.
The EPMA Journal (2020) Vol. 11, Iss. 4, pp. 645-659
Open Access | Times Cited: 35
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Shabarinath Nambiar, Dino B.A. Tan, Britt Clynick, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2021) Vol. 15, Iss. 2-3
Closed Access | Times Cited: 28
Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
Benjamin Seeliger, Alfonso Carleo, Pedro David Wendel‐Garcia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview
Sanjukta Dasgupta, Nilanjana Ghosh, Parthasarathi Bhattacharyya, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 60, Iss. 2, pp. 153-170
Closed Access | Times Cited: 22
Role of cellular senescence in inflammatory lung diseases
Cong Xie, Mai Maititusun Ya Likun, Qingli Luo, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 26-40
Closed Access | Times Cited: 12
An epidemiological introduction to human metabolomic investigations
Amit D. Joshi, Ali Rahnavard, Priyadarshini Kachroo, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 9, pp. 505-525
Open Access | Times Cited: 12
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
Franziska Roth‐Walter, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1089-1122
Open Access | Times Cited: 12
Molecular Pharmacognosy
Piyushkumar Sadhu, Mamta Kumari, Ghanshyam Parmar, et al.
(2025), pp. 395-420
Closed Access
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis—A Narrative Review
Oana Maria Catana, Alexandra Floriana Nemeş, Ramona Cioboată, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2611-2611
Open Access
Page 1 - Next Page

Scroll to top